Clinical trial
A Study of Two Doses of Intravenous NATRECOR hBNP (Nesiritide) in Patients With…
NCT00288730 · Scios, Inc., Industry · Completed
Key facts
| NCT number | NCT00288730 |
|---|---|
| Title | A Study of Two Doses of Intravenous NATRECOR hBNP (Nesiritide) in Patients With Worsening Congestive Heart Failure Who Have Difficulty Breathing at Rest |
| Official title | A Randomized, Double-Blinded, Placebo-Controlled Study of Two Doses of NATRECOR hBNP (Nesiritide) Administered as a Continuous Infusion in Subjects With Decompensated CHF |
| Lead sponsor | Scios, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Heart Failure, Congestive, Heart Decompensation |
| Intervention type | Drug |
| Interventions | nesiritide |
| Enrollment | 127 |
| Start date | Oct 1, 1996 |
| Completion | Aug 1, 1997 |
| First posted | Feb 8, 2006 |
| Last update posted | Jun 10, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: